Article 01 Aug 2025 Preserving Attorney-Client Privilege In Mergers And Acquisitions: Navigating The Common Interest Doctrine United States Commercial
Article 27 Jun 2025 Your Rights If FDA Agreed To Your Proposed Q1/Q2 ANDA Formulation But Sends A Refuse To Receive (RTR) Instead? United States Healthcare
Article 19 Mar 2025 Patent & Regulatory Legal Issues Related To Fertilizers, Fungicides, Pesticides, & Bulk Chemicals United States IP
Article 17 Mar 2025 Intellectual Property Issues Related To Artificial Intelligence: A Deeper Dive Into Patent, Copyright, & Trade Secrets Challenges United States IP
Article 10 Jan 2025 Pending 2025 FDA Legislation On Pharmaceutical Development & Marketing: A Comprehensive Industry Impact Analysis United States Healthcare
Article 19 Nov 2024 Infringing Your Own Intellectual Property: Understanding The Paradox United States IP
Article 17 Oct 2024 Proving Patent Infringement – Double Counting Pharmaceutical Ingredients When One Element Satisfies Two Claim Limitations United States IP
Article 28 Aug 2024 The Right To Repair Versus Reconstruction Under U.S. Patent Law: An In-Depth Analysis United States IP
Article 24 Jul 2024 Data Falsification/Data Integrity - You Can Run But You Cannot Hide United States Healthcare
Article 17 Jun 2024 Navigating Administrative Law: Understanding The Basics Of Challenging Federal Agency Decisions United States Healthcare
Article 16 May 2024 The Role Of Prior Art In Patent Law – Old And Admitted Prior Art United States IP
Article 16 May 2024 Five (5) & Ten (10) Year Data Exclusivity For New Drugs – When To File Generic Drug Applications United States IP
Article 16 May 2024 Billion Dollar Verdicts Wiped Out Due To Patent Law's Written Description United States IP
Article 16 May 2024 Ophthalmic, Parenteral, & Otic Drug Development: Does FDA's Draft Guidance Provide A Vehicle To Avoid Patent Problems? United States IP
Article 14 May 2024 Ice Hockey Referee And Patent Litigator – What On Earth Do These Have In Common? United States IP